Arcutis Biotherapeutics, Inc. (ARQT)
28.95
-0.07
(-0.24%)
USD |
NASDAQ |
Dec 15, 16:00
28.94
-0.01
(-0.03%)
After-Hours: 20:00
Arcutis Biotherapeutics Research and Development Expense (Annual): 76.42M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| CorMedix, Inc. | 3.942M |
| ADMA Biologics, Inc. | 1.813M |
| ANI Pharmaceuticals, Inc. | 44.58M |
| Editas Medicine, Inc. | 193.44M |
| Syndax Pharmaceuticals, Inc. | 241.64M |